Sonova Holding (OTCMKTS:SONVY) Given Consensus Rating of “Hold” by Brokerages

Sonova Holding (OTCMKTS:SONVY) has been assigned an average recommendation of “Hold” from the seven ratings firms that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, three have given a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company.

Several equities analysts recently commented on SONVY shares. UBS Group upgraded shares of Sonova from a “neutral” rating to a “buy” rating in a report on Wednesday. Citigroup reaffirmed a “sell” rating on shares of Sonova in a research note on Wednesday, May 13th. Finally, Morgan Stanley raised Sonova from an “underweight” rating to an “equal weight” rating in a research note on Tuesday, June 23rd.

Sonova Trading Up 5.3%

Shares of SONVY opened at $51.87 on Thursday. The company’s fifty day simple moving average is $50.22 and its 200-day simple moving average is $49.71. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.75 and a quick ratio of 1.43. Sonova has a twelve month low of $42.26 and a twelve month high of $61.09.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.